Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
38.75
+0.26 (0.68%)
Feb 21, 2025, 4:00 PM EST - Market closed
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $2.31 billion as of February 21, 2025. Its market cap has increased by 55.43% in one year.
Market Cap
2.31B
Enterprise Value
1.74B
1-Year Change
55.43%
Ranking
Category
Stock Price
$38.75
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.31B, an increase of 1,246.60%. That is a compound annual growth rate of 35.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.31B | 0.39% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 790.59B |
| UnitedHealth Group | 422.08B |
| Johnson & Johnson | 386.94B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.30B |
| Abbott Laboratories | 233.08B |
| AstraZeneca | 227.07B |
| Merck & Co. | 222.61B |